NCT00985647 - Pharmacokinetics of Lamivudine at Two Different Doses | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions

HIV Infections

Interventions

DRUG

Lamivudine (3TC)

"3TC 300mg/150mg participants will receive 3TC 300 mg (2 x 150 mg tablet) once daily for 10 days, washout for 10 days and then 3TC 150 mg (1 x 150 mg tablet) once daily for 10 days.~3TC 150mg/300mg participants will receive 3TC 150 mg (1 x 150 mg tablet) once daily for 10 days, washout for 10 days and then 3TC 300 mg (2 x 150 mg tablet) once daily for 10 days."

Trial Locations (1)

Unknown

St Stephen's Centre, Chelsea and Westminster Hospital, London